| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2328091-01-4 | tert-Butyl (7-bromopyrrolo(2,1-f)(1,2,4)triazin-4-yl)carbamate | C11H13BrN4O2 |
| 2331211-57-3 | (1S,3R)-3-Amino-cyclohexanol hydrochloride | C6H14ClNO |
| 2332841-25-3 | TBAJ-876;(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,6-dimethoxypyridin-4-yl)-4-(dimethylamino)-1-(2,3,6-trimethoxypyridin-4-yl)butan-2-ol | C31H37BrN4O7 |
| 2344681-17-8 | Tert-butyl 2,2-dioxo-2lambda6-thia-3,8-diazaspiro(4.5)decane-8-carboxylate | C12H22N2O4S |
| 2344685-75-0 | 8-Oxa-2-thia-3-azaspiro(4.5)decane 2,2-dioxide;8-oxa-2λ6-thia-3-azaspiro(4.5)decane 2,2-dioxide | C7H13NO3S |
| 2346620-55-9 | 2',3'-O-(1-methylethylidene)-Uridine 4-oxime 5'-(2-methylpropanoate);((3aR,4R,6R,6aR)-4-(4-(hydroxyamino)-2-oxopyrimidin-1-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro(3,4-d)(1,3)dioxol-6-yl)methyl 2-methylpropanoate | C16H23N3O7 |
| 2348441-63-2 | Aprepitant EP Impurity C;5-(((2R,3S)-2-((1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluorobiphenyl-4-yl)morpholin-4-yl)methyl)-1,2-dihydro-3H-1,2,4-triazol-3-one | C29H25F7N4O3 |
| 2355229-03-5 | 2-Bromo-7-chlorodibenzo(b,d)furan | C12H6BrClO |
| 2356153-95-0 | Celecoxib Impurity 5;1-(4-sulfamoylphenyl)-5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazole 2-oxide | C17H14F3N3O3S |
| 2357109-89-6 | 3-Hydroxy-1-(4-methoxybenzyl)piperidine-2,6-dione | C13H15NO4 |
| 2360830-97-1 | 7-Chloro-1-phenyldibenzo(b,d)furan | C18H11ClO |
| 2360931-42-4 | 3,3-Dimethoxycyclobutanecarboxamide | C7H13NO3 |
| 2361297-58-5 | 7-(4H-1,3-dioxin-2-yl)-8-hydroxy-9-methoxy-3-methyl-4H-chromeno(3,4-c)pyridin-5-one;D-F07 | C18H17NO6 |
| 2361613-60-5 | 2-{4-Bromo-1-(5-(2-methyl-2-propanyl)-2-biphenylyl)-1H-benzimidazol-2-yl}-4,6-bis(2-methyl-2-propanyl)phenol | C37H41BrN2O |
| 2366209-97-2 | 6-Bromo-1-phenylnaphthalene | C16H11Br |
| 2366210-03-7 | 2-(4-Chlorophenyl)-1-phenylnaphthalene | C22H15Cl |
| 2369979-68-8 | JHU37160 (DREADD ligand);3-chloro-6-(4-ethylpiperazin-1-yl)-10-fluoro-11H-benzo(b)(1,4)benzodiazepine | C19H20ClFN4 |
| 2375259-86-0 | (5,5-Dimethyl-3-pyrrolidinyl)acetic acid hydrochloride | C8H16ClNO2 |
| 2375281-44-8 | NF-kappaBeta activator 2;3-(2-(2-fluoroanilino)-1,3-oxazol-5-yl)benzoic acid | C16H11FN2O3 |
| 2375421-09-1 | SR-717 lithium;lithium 4,5-difluoro-2-((6-imidazol-1-ylpyridazine-3-carbonyl)amino)benzoate | C15H8F2LiN5O3 |
| 2375865-91-9 | Rosuvastatin Impurity 18;tert-butyl 2-((4S,6R)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | C15H26O6 |
| 2376990-29-1 | Thalidomide-O-C4-NH2 (hydrochloride);4-(4-Aminobutoxy)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione hydrochloride (1:1) | C17H20ClN3O5 |
| 2377770-18-6 | (2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid | C16H18NO5P |
| 2378356-17-1 | 2'-(9H-Carbazol-9-yl)-(1,1'-biphenyl)-4-amine;4-(2-carbazol-9-ylphenyl)aniline | C24H18N2 |
| 2379402-85-2 | Bortezomib Impurity 5;Deu3MZ2AN8;(S)-N-(1-(3-hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | C19H22N4O4 |
| 2379694-79-6 | 1,10-Phenanthroline-3,8-dicarboxylic acid | C14H8N2O4 |
| 2380027-49-4 | Src Inhibitor 3;N-(3-chloro-4-((6-methoxypyrazolo(1,5-a)pyridine-3-carbonyl)amino)phenyl)-1-(1-(3-cyano-3-methylbutanoyl)piperidin-4-yl)-5-fluoroindazole-3-carboxamide | C34H32ClFN8O4 |
| 2380230-73-7 | 2-(2-((3-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)phenyl)carbonylamino)phenyl)ethanoic acid | C27H29N3O3 |
| 2381400-91-3 | 2-Methyl-2-propanyl (4S)-4-amino-3,3-difluoro-1-pyrrolidinecarboxylate;(4S)-4-Amino-3,3-difluoro-1-pyrrolidinecarboxylate de 2-m�thyl-2-propanyle | C9H16F2N2O2 |
| 2381854-90-4 | Fmoc-N-Me-3-(4-py)-L-Ala;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(pyridin-4-yl)propanoic acid | C24H22N2O4 |
| 2384108-14-7 | Cefazolin EP Impurity B;Cefazolin pivaloyl; (6R,7R)-7-(2,2-dimethylpropanoylamino)-3-((5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | C16H20N4O4S3 |
| 2387518-94-5 | 4-((1,2,4)Triazolo(1,5-a)pyridin-7-yloxy)-2-fluoro-3-methylaniline;2-fluoro-3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)aniline | C13H11FN4O |
| 2387538-18-1 | 2-Chloro-4-neopentylpyridine | C10H14ClN |
| 2387728-91-6 | 1-(4-Ethoxy-3-(hydroxymethyl)phenyl)-2-((2-methyl-2-propanyl)amino)ethanol | C15H25NO3 |
| 2389125-23-7 | Y6-BO-4F;2-((2Z)-2-((23-((Z)-(1-(dicyanomethylidene)-5,6-difluoro-3-oxoinden-2-ylidene)methyl)-3,27-di(undecan-5-yl)-8,22-di(undecyl)-6,10,15,20,24-pentathia-3,14,16,27-tetrazaoctacyclo(16.9.0.02,12.04,11.05,9.013,17.019,26.021,25)heptacosa-1(18),2(12),4(11),5(9),7,13,16,19(26),21(25),22-decaen-7-yl)methylidene)-5,6-difluoro-3-oxoinden-1-ylidene)propanedinitrile | C88H98F4N8O2S5 |
| 2392930-05-9 | 2-Chloro-4,6-di(dibenzofuran-1-yl)-1,3,5-triazine | C27H14ClN3O2 |
| 2396570-49-1 | 2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine | C30H21N9 |
| 2402776-84-3 | Baricitinib Impurity 16;2-(3-(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile | C23H27N9O4S2 |
| 2407535-11-7 | 5-((1-(3-Fluoropropyl)azetidin-3-yl)amino)pyridine-2-carbaldehyde | C12H16FN3O |
| 2408053-56-3 | Sacubitril Methyl Ester;4-(((2S,4R)-1-((1,1'-Biphenyl)-4-yl)-5-methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C23H27NO5 |
| 2408294-08-4 | Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II) | C39H49FeNO3P2PdS |
| 2408495-96-3 | Budesonide 21-Butyrate Impurity;(2-((1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo(10.8.0.02,9.04,8.013,18)icosa-14,17-dien-8-yl)-2-oxoethyl) butanoate | C29H40O7 |
| 2408968-92-1 | (1-(Aminomethyl)-2-oxabicyclo(3.1.1)heptan-5-yl)methanol hydrochloride | C8H16ClNO2 |
| 2409005-96-3 | 3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(6-bromo-5-fluoro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H10BrFN2O3 |
| 2409479-29-2 | (R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo(d)imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;BAY-985 | C27H30F3N9O |
| 2409562-95-2 | 1-Bromo-5-(tert-butyl)-2,3-dichlorobenzene | C10H11BrCl2 |
| 2410075-48-6 | 7-Ketoabiraterone acetate;((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-pyridin-3-yl-1,2,3,4,8,9,11,12,14,15-decahydrocyclopenta(a)phenanthren-3-yl) acetate | C26H31NO3 |
| 2410284-90-9 | Nintedanib Impurity 33;Dimethyl 3,3'-(((((2,2'-(piperazine-1,4-diyl)bis(acetyl))bis(methylazanediyl))bis(4,1-phenylene))bis(azanediyl))bis(phenylmethanylylidene))(3Z,3'E)-bis(2-oxoindoline-6-carboxylate) | C56H52N8O8 |
| 2410401-58-8 | N-(Dibenzo(b,d)furan-3-yl)-9-phenyl-9H-carbazol-2-amine | C30H20N2O |
| 2413185-88-1 | Oseltamivir Impurity 13;Ethyl (1S,5S,6S)-5-(Pentan-3-yloxy)-7-oxabicyclo(4.1.0)hept-3-ene-3-carboxylate | C14H22O4 |